Caroline Marshall
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 16
-
- Nosocomial Infections in ICU 11
- Co-authors
- Kirsty BuisingKarin ThurskyAndrew ForbesElizabeth A. GrabschMalcolm McDonaldBeverley‐Ann BiggsKarin LederKatherine B. Gibney
- Journals
- Infection Disease & Health (13 papers)The Medical Journal of Australia (11 papers)Infection Control and Hospital Epidemiology (9 papers)Vaccine (7 papers)American Journal of Infection Control (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Caroline Marshall
116 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 135
- Applied Microbiology and Biotechnology 464
- Clinical Biochemistry 304
- Infectious Diseases 775
- Geriatrics and Gerontology 103
- Critical Care and Intensive Care Medicine 133
Countries citing papers authored by Caroline Marshall
This map shows the geographic impact of Caroline Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Marshall more than expected).
Fields of papers citing papers by Caroline Marshall
This network shows the impact of papers produced by Caroline Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Marshall. The network helps show where Caroline Marshall may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caroline Marshall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 34 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 9 | |
| 7 | Early clinical response to a high consequence infectious disease outbreak at the Royal Melbourne Hospital Emergency Department – insights from COVID-19 | 2020 | 3 |
| 8 | 2020 | 1 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 15 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 12 | |
| 15 | 2019 | 13 | |
| 16 | 2014 | 14 | |
| 17 | 2013 | 36 | |
| 18 | 2012 | 5 | |
| 19 | 2001 | 4 | |
| 20 | 1952 | 13 |
About Caroline Marshall
Caroline Marshall is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Clinical Biochemistry, Infectious Diseases and Molecular Medicine, having authored 120 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (20 papers), Bacterial Identification and Susceptibility Testing (17 papers), Patient Satisfaction in Healthcare (16 papers), Antibiotic Use and Resistance (16 papers), Surgical site infection prevention (13 papers), Nosocomial Infections in ICU (11 papers), Infection Control in Healthcare (10 papers) and COVID-19 and healthcare impacts (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (464 citations), Clinical Biochemistry (304 citations), Infectious Diseases (775 citations), Geriatrics and Gerontology (103 citations) and Critical Care and Intensive Care Medicine (133 citations). Caroline Marshall has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kirsty Buising, Karin Thursky, Andrew Forbes, Elizabeth A. Grabsch, Malcolm McDonald, Beverley‐Ann Biggs, Karin Leder, Katherine B. Gibney, Steve Wesselingh and Emma S. McBryde. Their work appears in journals such as Infection Disease & Health, The Medical Journal of Australia, Infection Control and Hospital Epidemiology, Vaccine and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.